Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares trading hands. The stock had previously closed at $0.31.
Sino Biopharmaceutical Stock Performance
The firm’s 50 day moving average is $0.36 and its 200 day moving average is $0.39.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Read More
- Five stocks we like better than Sino Biopharmaceutical
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 4/29 – 5/3
- What Are Growth Stocks and Investing in Them
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Which Wall Street Analysts are the Most Accurate?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
